Pestal Kathleen, Funk Cory C, Snyder Jessica M, Price Nathan D, Treuting Piper M, Stetson Daniel B
Department of Immunology, University of Washington School of Medicine, Seattle, WA 98195, USA.
Institute for Systems Biology, Seattle, WA 98195, USA.
Immunity. 2015 Nov 17;43(5):933-44. doi: 10.1016/j.immuni.2015.11.001.
Mutations in ADAR, which encodes the ADAR1 RNA-editing enzyme, cause Aicardi-Goutières syndrome (AGS), a severe autoimmune disease associated with an aberrant type I interferon response. How ADAR1 prevents autoimmunity remains incompletely defined. Here, we demonstrate that ADAR1 is a specific and essential negative regulator of the MDA5-MAVS RNA sensing pathway. Moreover, we uncovered a MDA5-MAVS-independent function for ADAR1 in the development of multiple organs. We showed that the p150 isoform of ADAR1 uniquely regulated the MDA5 pathway, whereas both the p150 and p110 isoforms contributed to development. Abrupt deletion of ADAR1 in adult mice revealed that both of these functions were required throughout life. Our findings delineate genetically separable roles for both ADAR1 isoforms in vivo, with implications for the human diseases caused by ADAR mutations.
编码ADAR1 RNA编辑酶的ADAR基因突变会导致Aicardi-Goutières综合征(AGS),这是一种与异常I型干扰素反应相关的严重自身免疫性疾病。ADAR1如何预防自身免疫尚不完全清楚。在此,我们证明ADAR1是MDA5-MAVS RNA传感途径的特异性和必需负调节因子。此外,我们发现ADAR1在多个器官发育中具有不依赖于MDA5-MAVS的功能。我们表明,ADAR1的p150亚型独特地调节MDA5途径,而p150和p110亚型都对发育有贡献。成年小鼠中ADAR1的突然缺失表明,这两种功能在整个生命过程中都是必需的。我们的研究结果描绘了ADAR1两种亚型在体内的基因可分离作用,这对由ADAR突变引起的人类疾病具有启示意义。